CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Neuromuscular electrical stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02739620
NCT02739620N/ACompleted
CompareCT.gov

Alternative Exercise Program to Improve Skeletal Muscle Function and Fatigue in Cancer Survivors

University of Vermont·interventional·Posted Apr 15, 2016·Updated Apr 11, 2023

In Brief

A clinical study evaluating Neuromuscular electrical stimulation for Breast Cancer. Completed, enrolled 22 participants across 1 site.

Detailed Summary

Exercise training has beneficial effects in cancer survivors to minimize some of the side effects of cancer and its treatment and improve long-term prognosis, but there are numerous hurdles for individuals diagnosed with, and being treated for, cancer to participate in exercise programs. The goal of this research study is to begin to evaluate whether exercise training via neuromuscular electrical stimulation (NMES) has beneficial effects on skeletal muscle size and function in cancer survivors.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 15, 2016
Enrollment StartOct 1, 2017
Primary CompletionDec 2, 2019
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 10.2 years ago

Interventions

Neuromuscular electrical stimulationdevice

Neuromuscular electrical stimulation will be performed 5 times/week for one hour each day for 2 months.